|
New Approval for Boston Scientific—Europe Sets the Pace for FDA
|
Erik Mellgren |
05/08/08 |
|
No Comments
|
|
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News
|
Rebecca Zacks |
05/07/08 |
|
No Comments
|
|
Medicare Will Cover Abiomed Heart
|
Wade Roush |
05/02/08 |
|
No Comments
|
|
InfraReDx Gets FDA Nod for Artery-Imaging Tool
|
Rebecca Zacks |
04/30/08 |
|
No Comments
|
|
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
|
Rebecca Zacks |
04/23/08 |
|
No Comments
|
|
FDA Decision a Blow For Genzyme—and Biogenerics?
|
Rebecca Zacks |
04/22/08 |
|
1 Comment
|
|
Patent Reform Blocked, Epix Deal Expanded, Repligen Suit Settled, & More Life Sciences News
|
Rebecca Zacks |
04/09/08 |
|
No Comments
|
|
Thermo Fisher MRSA Test Approved
|
Rebecca Zacks |
04/04/08 |
|
No Comments
|
|
Vertex on the Rise, Sirtris on TV, an IPO (Finally) on the Table, and More Life Sciences News
|
Rebecca Zacks |
04/02/08 |
|
No Comments
|
|
Repligen Launches Trial of Imaging Agent
|
Rebecca Zacks |
03/26/08 |
|
No Comments
|
|
Cancer Patient Can Use Newton Firm’s Drug, FDA Says
|
Rebecca Zacks |
03/24/08 |
|
No Comments
|
|
Exact’s Colon Cancer Test Included in Medical Organization Recommendations
|
Rebecca Zacks |
03/06/08 |
|
No Comments
|
|
Biogen’s Busy Week, Alnylam’s Big Announcement, Targanta’s and Momenta’s Growing Executive Ranks, & More Life Sciences News
|
Rebecca Zacks |
03/05/08 |
|
No Comments
|
|
Biogen Bouncing Back From Tysabri Warning News
|
Rebecca Zacks |
02/28/08 |
|
1 Comment
|
|
Three FDA Approvals for Boston Scientific Cardiac Division
|
Rebecca Zacks |
02/25/08 |
|
No Comments
|
|
GTC Biotherapeutics, Racing Against Time to Prove the Worth of “Pharming”
|
David Stipp |
02/11/08 |
|
No Comments
|
|
GTC Biotherapeutics Drug Passes Clinical Milestone, Helping Blaze the Trail for U.S. “Pharming”
|
David Stipp |
02/05/08 |
|
No Comments
|
|
Artificial Heart Finally Ready for Market? Abiomed’s Potential “Billion-Dollar Monopoly”
|
Rebecca Zacks |
01/23/08 |
|
1 Comment
|
|
Hologic Grabs $82M for Drug
|
Rebecca Zacks |
01/22/08 |
|
No Comments
|
|
ConforMIS Device Gets EU Approval
|
Rebecca Zacks |
01/17/08 |
|
No Comments
|
|
NitroMed Ends BiDil Marketing, Slashes Staff
|
Rebecca Zacks |
01/16/08 |
|
No Comments
|
|
Biogen Idec’s Tysabri Approved for Crohn’s
|
Rebecca Zacks |
01/14/08 |
|
No Comments
|
|
Obesity Startup Gelesis Gobbles Up $16M in Financing
|
Rebecca Zacks |
01/03/08 |
|
1 Comment
|
|
Sepracor Licenses Epilepsy Drug
|
Robert Buderi |
01/02/08 |
|
No Comments
|
|
Abiomed Device Approved
|
Rebecca Zacks |
12/19/07 |
|
No Comments
|
|
Hologic Contraceptive Device Gets Nod From FDA Panel
|
Rebecca Zacks |
12/14/07 |
|
No Comments
|
|
GTC Drug Gets Orphan Status
|
Rebecca Zacks |
12/10/07 |
|
No Comments
|
|
NitroMed is Feeling the Pressure but Still Betting on Marketing to Save BiDil
|
Malorye Allison |
11/28/07 |
|
No Comments
|
|
Genzyme Arthritis Treament Approval Delayed
|
Rebecca Zacks |
11/13/07 |
|
1 Comment
|
|
Setback for Momenta, Setback for Biogenerics?
|
Rebecca Zacks |
11/08/07 |
|
No Comments
|
